Silk fibroin and hydroxypropyl cellulose composite injectable hydrogel-containing extracellular vesicles for myocardial infarction repair.
Yinjian HuaZhengfei HeYunjie NiLinggang SunRui WangYan LiXintong LiGuohua JiangPublished in: Biomedical physics & engineering express (2024)
Extracellular vesicles (EVs) have been recognized as one of the promising specific drugs for myocardial infarction (MI) prognosis. Nevertheless, low intramyocardial retention of EVs remains a major impediment to their clinical application. In this study, we developed a silk fibroin/hydroxypropyl cellulose (SF/HPC) composite hydrogel combined with AC16 cell-derived EVs targeted modification by folic acid for the treatment of acute myocardial infarction repair. EVs were functionalized by distearoylphosphatidyl ethanolamine-polyethylene glycol (DSPE-PEG-FA) via noncovalent interaction for targeting and accelerating myocardial infarction repair. In vitro , cytocompatibility analyses revealed that the as-prepared hydrogels had excellent cell viability by MTT assay and the functionalized EVs had higher cell migration by scratch assay. In vivo , the composite hydrogels can promote myocardial tissue repair effects by delaying the process of myocardial fibrosis and promoting angiogenesis of infarct area in MI rat model.
Keyphrases
- tissue engineering
- left ventricular
- wound healing
- acute myocardial infarction
- drug delivery
- hyaluronic acid
- cell migration
- heart failure
- cancer therapy
- high throughput
- quantum dots
- endothelial cells
- percutaneous coronary intervention
- drug release
- ionic liquid
- atrial fibrillation
- extracellular matrix
- coronary artery disease
- single cell
- liver fibrosis
- smoking cessation